VTGN Vistagen Therapeutics, Inc.

19d ago, source: Seeking Alpha

Vistagen Therapeutics, Inc., a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other ...

Investornewsbreaks Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation At Upcoming Anxiety And Depression Association Conference

13d ago, source:

Vistagen Therapeutics (NASDAQ: VTGN ), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies f ...

Vistagen Therapeutics Inc VTGN

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vistagen Therapeutics Inc VTGN

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

VistaGen Therapeutics Inc.

26d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

VistaGen Therapeutics Inc (VTGN)

1mon ago, source: Investing

VistaGen Therapeutics (VTGN) reported Q2 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Orbimed Advisors reduced stake in Graybug Vision, Inc. ByInvesting.com • Apr 20 ...

VistaGen Therapeutics Inc (VTGN)

15d ago, source: Investing

On the 25th of March, Orbimed Advisors sold 313 thousand Graybug Vision, Inc. (GRAY) shares for $1.9 million at an average price of $6.16 per share. Shares of Graybug Vision, Inc.... Investing.com ...

VistaGen Therapeutics Inc

25d ago, source: U.S. News & World Report

A slump in renewable energy stocks means long-term opportunities aren't baked into some valuations.

VistaGen Therapeutics Inc (VTGN)

1mon ago, source: Investing

Vistagen Therapeutics, Inc., a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other central ...

VistaGen Therapeutics Inc (VTGN)

22d ago, source: Investing

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking ...